New Mexico Educational Retirement Board Sells 1,600 Shares of Danaher Co. (NYSE:DHR)

New Mexico Educational Retirement Board reduced its stake in shares of Danaher Co. (NYSE:DHR) by 5.0% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 30,635 shares of the conglomerate’s stock after selling 1,600 shares during the period. New Mexico Educational Retirement Board’s holdings in Danaher were worth $7,032,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of DHR. Heck Capital Advisors LLC bought a new position in Danaher during the 4th quarter worth $27,000. Decker Retirement Planning Inc. bought a new position in shares of Danaher in the 4th quarter worth about $31,000. Golden State Wealth Management LLC bought a new stake in Danaher in the 4th quarter valued at about $31,000. Strategic Financial Concepts LLC bought a new stake in Danaher in the 4th quarter valued at about $31,000. Finally, Pineridge Advisors LLC increased its position in Danaher by 63.3% in the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock valued at $34,000 after buying an additional 57 shares in the last quarter. 79.05% of the stock is owned by institutional investors.

Danaher Price Performance

Danaher stock opened at $206.66 on Friday. Danaher Co. has a 12 month low of $196.80 and a 12 month high of $281.70. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The business’s 50 day simple moving average is $230.00 and its 200 day simple moving average is $249.96. The company has a market cap of $149.26 billion, a price-to-earnings ratio of 39.14, a PEG ratio of 2.68 and a beta of 0.83.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the prior year, the business earned $2.09 EPS. Sell-side analysts forecast that Danaher Co. will post 7.67 EPS for the current year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were issued a dividend of $0.27 per share. The ex-dividend date of this dividend was Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.52%. Danaher’s payout ratio is 20.45%.

Insider Buying and Selling at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the sale, the senior vice president now owns 20,230 shares of the company’s stock, valued at $4,534,149.90. The trade was a 21.98 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 11.10% of the company’s stock.

Wall Street Analyst Weigh In

DHR has been the subject of a number of research analyst reports. UBS Group decreased their target price on Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a research report on Wednesday, October 23rd. Royal Bank of Canada reiterated an “outperform” rating and set a $277.00 price target (down previously from $299.00) on shares of Danaher in a research note on Thursday, January 30th. Citigroup cut their price target on Danaher from $285.00 to $265.00 and set a “buy” rating for the company in a research note on Thursday, January 30th. Guggenheim began coverage on Danaher in a research note on Thursday, December 19th. They set a “buy” rating and a $275.00 price target for the company. Finally, Robert W. Baird cut their target price on Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Seven analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $278.00.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.